Clinical Trial Update: CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction [NA]

View source ↗

Summary

Clinical trial update for CardiAMP Heart Failure II in patients with ischemic heart failure with reduced ejection fraction; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• CardiAMP

Snippet

Sponsor: BioCardia, Inc. | Conditions: Ischemic Heart Failure | NA | Status: RECRUITING